Retrospective analysis of human adenovirus infection prevalence in children with respiratory tract infections following the COVID-19 pandemic in Shaoxing.
{"title":"Retrospective analysis of human adenovirus infection prevalence in children with respiratory tract infections following the COVID-19 pandemic in Shaoxing.","authors":"Jianwei Zhang, Jinlong Ding, Xinqi Ma","doi":"10.1016/j.diagmicrobio.2026.117747","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Human adenovirus (HAdV) activity has changed across Chinese regions during the transition from COVID-19 containment to subsequent years. We examined whether HAdV positivity among children hospitalized with acute respiratory infections (ARIs) in Shaoxing increased from 2022 to 2024 and described its distribution by age, season, and clinical presentation.</p><p><strong>Methods: </strong>This single-center retrospective study included 9,714 hospitalized children aged <14 years with ARIs from January 2022 through December 2024. Respiratory specimens were tested for HAdV DNA using fluorescent probe-based polymerase chain reaction (PCR). Positivity was calculated among tested children, and clinical findings were summarized among HAdV-positive patients.</p><p><strong>Results: </strong>HAdV was detected in 461 children (4.75%). Reported annual positivity increased from 0.85% in 2022 to 2.07% in 2023 and 8.99% in 2024. Based on the tabulated counts, positivity was 1.15%, 5.03%, 7.42%, and 7.74% in children aged <1, 1-<3, 3-<5, and ≥5 years, respectively. Summer had the highest pooled seasonal positivity (190/2,275; 8.35%). Positivity was 5.10% in lower ARIs and 3.60% in upper ARIs. Among HAdV-positive children, fever occurred in 415 (90.02%), cough in 370 (80.26%), and lower ARIs in 378 (82.00%).</p><p><strong>Conclusions: </strong>HAdV positivity increased among tested pediatric inpatients in Shaoxing from 2022 to 2024, with higher pooled positivity in older age groups and summer. These findings support continued hospital surveillance, including molecular typing to investigate circulating types.</p><p><strong>Importance: </strong>The transmission route of HAdV is similar to that of COVID-19, suggesting that the effect of non-drug intervention on the two may be equivalent. The purpose of this study was to analyze the epidemiological characteristics of HAdV infection in children in Shaoxing from 2022 to 2024. This study explored the impact of COVID-19 and non-drug interventions on the prevalence of HAdV, and provided guidance for disease treatment and infection prevention.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117747"},"PeriodicalIF":1.8000,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostic microbiology and infectious disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.diagmicrobio.2026.117747","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Human adenovirus (HAdV) activity has changed across Chinese regions during the transition from COVID-19 containment to subsequent years. We examined whether HAdV positivity among children hospitalized with acute respiratory infections (ARIs) in Shaoxing increased from 2022 to 2024 and described its distribution by age, season, and clinical presentation.
Methods: This single-center retrospective study included 9,714 hospitalized children aged <14 years with ARIs from January 2022 through December 2024. Respiratory specimens were tested for HAdV DNA using fluorescent probe-based polymerase chain reaction (PCR). Positivity was calculated among tested children, and clinical findings were summarized among HAdV-positive patients.
Results: HAdV was detected in 461 children (4.75%). Reported annual positivity increased from 0.85% in 2022 to 2.07% in 2023 and 8.99% in 2024. Based on the tabulated counts, positivity was 1.15%, 5.03%, 7.42%, and 7.74% in children aged <1, 1-<3, 3-<5, and ≥5 years, respectively. Summer had the highest pooled seasonal positivity (190/2,275; 8.35%). Positivity was 5.10% in lower ARIs and 3.60% in upper ARIs. Among HAdV-positive children, fever occurred in 415 (90.02%), cough in 370 (80.26%), and lower ARIs in 378 (82.00%).
Conclusions: HAdV positivity increased among tested pediatric inpatients in Shaoxing from 2022 to 2024, with higher pooled positivity in older age groups and summer. These findings support continued hospital surveillance, including molecular typing to investigate circulating types.
Importance: The transmission route of HAdV is similar to that of COVID-19, suggesting that the effect of non-drug intervention on the two may be equivalent. The purpose of this study was to analyze the epidemiological characteristics of HAdV infection in children in Shaoxing from 2022 to 2024. This study explored the impact of COVID-19 and non-drug interventions on the prevalence of HAdV, and provided guidance for disease treatment and infection prevention.
期刊介绍:
Diagnostic Microbiology and Infectious Disease keeps you informed of the latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. Packed with rigorously peer-reviewed articles and studies in bacteriology, immunology, immunoserology, infectious diseases, mycology, parasitology, and virology, the journal examines new procedures, unusual cases, controversial issues, and important new literature. Diagnostic Microbiology and Infectious Disease distinguished independent editorial board, consisting of experts from many medical specialties, ensures you extensive and authoritative coverage.